Phase 1 trial to evaluate Ad-RTS-hIL-12 plus veledimex in combination with nivolumab for treatment ...
Conference Call and Webcast Scheduled for 8:30 AM ET RA’ANANA, Israel and NEW YORK, March ...
– Chi-Med makes additional FRESCO presentations at ASCO 2018, following oral presentation at ASCO ...
